A second duodenal biopsy is necessary in the follow-up of adult coeliac patients

References

• Biagi F, Gobbi P, Marchese A, Borsotti E, Zingone F, Ciacci C, et al. Low incidence but poor prognosis of complicated coeliac disease: a retrospective multicentre study. Dig Liver Dis. 2014;46:227–30.
   PubMedGoogle Scholar
• Howdle PD, Losowsky MS. Coeliac disease in adults. In: Marsh MN, editor. Coeliac disease. Oxford, UK: Blackwell; 1992. p. 49–80.
   Google Scholar
• Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76.
   PubMed Web of Science ®Google Scholar
• Nasr I, Leffler DA, Ciclitira PJ. Management of celiac disease. Gastrointest Endoscopy Clin N Am. 2012;22:695–704.
   Google Scholar
• Biagi F, Bianchi PI, Campanella J, Badulli C, Martinetti M, Klersy C, et al. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy. A follow-up study. J Clin Pathol. 2008;61:1116–18.
   PubMed Web of Science ®Google Scholar
• Biagi F, Pezzimenti D, Campanella J, Vadacca GB, Corazza GR. Endomysial and tissue transglutaminase antibodies in coeliac sera. A comparison not influenced by previous serological testing.Scand J Gastroenterol. 2001;36:955–8.
   PubMed Web of Science ®Google Scholar
• Biagi F, Bianchi PI, Campanella J, Zanellati G, Corazza GR. The impact of misdiagnosing celiac disease at a referral centre. Can J Gastroenterol. 2009;23:543–5.
   PubMedGoogle Scholar
• Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford, UK: Blackwell Scientific Publications; 1987. p. 127–9, 334–41.
   Google Scholar
• Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.
   Web of Science ®Google Scholar
• Corazza GR, Villanacci V. Coeliac disease. J Clin Pathol. 2005; 58:573–4.
   PubMed Web of Science ®Google Scholar
• Herman ML, Rubio-Tapia A, Lahr BD, Larson JJ, Van Dyke CT, Murray JA. Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol. 2012;10:893–9.
   PubMed Web of Science ®Google Scholar
• Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology. 2005;128:S135–41.
   PubMed Web of Science ®Google Scholar
• Dipper CR, Maitra S, Thomas R, Lamb CA, McLean-Tooke AP, Ward R, et al. Anti-tissue transglutaminase antibodies in the follow up of adult coeliac disease. Aliment Pharmacol Ther. 2009;30:236–44.
   PubMed Web of Science ®Google Scholar
• Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e9–14.
   PubMedGoogle Scholar
• Case S. The gluten-free diet: how to provide effective education and resources. Gastroenterology. 2005;128:S128–34.
   PubMed Web of Science ®Google Scholar
• Biagi F, Bianchi PI, Marchese A, Trotta L, Vattiato C, Balduzzi D, et al. A score that verifies adherence to a gluten-free diet: a cross- sectional, multicentre validation in real clinical life. Br J Nutr. 2012;108:1884–8.
   Google Scholar
• Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530–6.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412–20.
   PubMed Web of Science ®Google Scholar
• Kaukinen K, Sulkanen S, Maki M, Collin P. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol. 2002;14:311–15.
   PubMed Web of Science ®Google Scholar
• Troncone R, Mayer M, Spagnuolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable marker for slight dietary transgressions in adolescents with coeliac disease. J Pediatr Gastroenterol Nutr. 1995; 21:69–72.
   PubMed Web of Science ®Google Scholar
• Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol. 2000;95:712–14.
   PubMed Web of Science ®Google Scholar
• Biagi F, Campanella J, Martucci S, Pezzimenti D, Ciclitira PJ, Ellis HJ, et al. A milligram of gluten a day keeps the mucosal recovery away. Nutr Rev. 2004;62:360–3.
   PubMed Web of Science ®Google Scholar
• Silvester JA, Rashid M. Long-term follow up of individuals with celiac disease: an evaluation of current practice guideline. Can J Gastroenterol. 2007;21:557–64.
   PubMed Web of Science ®Google Scholar
• Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;1042–66.
   Google Scholar
• Bardella MT, Velio P, Cesana BM, Prampolini L, Casella G, Di Bella C, et al. Coeliac disease: a histological follow-up study. Histopathology. 2007;50:465–71.
   PubMed Web of Science ®Google Scholar
• Elfström P, Granath F, Ekström Smedby K, Montgomery SM, Askling J, Ekbom A, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst. 2011;103:436–44.
   PubMedGoogle Scholar
• Hære P, Høie O, Schulz TB, Lundin KEA. Mucosal healing in Norwegian celiac patients. Abstract book 15th International Celiac Disease Symposium; Chicago 2013;8:I909, 22–25 September 2013.
   Google Scholar
• Hutchinson JM, West NP, Robins GG, Howdle PD. Long-term histological follow up with coeliac disease in a UK teaching hospital. QJM. 2010;103:511–17.
   PubMed Web of Science ®Google Scholar